SCHEMBL183532

SCHEMBL183532

CC(=O)c1ccc(C)o1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL54682 0.84 KMT2A (0.46)
SCHEMBL9349735 0.82 KLK7 (0.57)
SCHEMBL19681459 0.82 KLK7 (0.57)
SCHEMBL11539386 0.81 KLK7 (0.52)
SCHEMBL143244 0.80
SCHEMBL10675360 0.79
SCHEMBL353183 0.78
SCHEMBL279424 0.78
SCHEMBL28967674 0.78 KLK7 (0.53)
Hydrochloric Acid SCHEMBL3047201 0.78 KLK7 (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1070 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260096574-A1 CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS VOYAGE FOODS INC (US) 2026-04-09 US claimed
US-20260007144-A1 CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS VOYAGE FOODS INC (US) 2026-01-08 US claimed
EP-4672967-A2 ALTERNATIVE COFFEE BEVERAGES Compound Foods Inc. (US) 2026-01-07 EP claimed
US-12496370-B2 Freshening compositions comprising controlled release modulators Arylessence, Inc. (US) 2025-12-16 US claimed
US-20250344991-A1 COMPOSITIONS AND METHODS FOR A UNIVERSAL CLINICAL TEST FOR OLFACTORY DYSFUNCTION UNIV ROCKEFELLER (US) 2025-11-13 US claimed
EP-4627940-A1 COMPOSITIONS AND METHODS Nicoventures Trading Limited (GB) 2025-10-08 EP claimed
EP-4627939-A1 METHODS Nicoventures Trading Limited (GB) 2025-10-08 EP claimed
EP-4627942-A1 COMPOSITIONS AND METHODS Nicoventures Trading Limited (GB) 2025-10-08 EP claimed
EP-4627941-A1 COMPOSITIONS AND METHODS Nicoventures Trading Limited (GB) 2025-10-08 EP claimed
EP-4627943-A1 COMPOSITIONS AND METHODS Nicoventures Trading Limited (GB) 2025-10-08 EP claimed
EP-2517573-A1 FLAVOR-IMPROVING MATERIAL Ajinomoto Co., Inc. (JP) 2012-10-31 EP claimed
US-20120269947-A1 FLAVOR IMPROVING MATERIALS AJINOMOTO CO., INC. (JP) 2012-10-25 US claimed
CN-102503894-A 5-substituted methylene imidazolidine-2, 4-diketone derivative as well as pharmaceutical composition and application thereof UNIV TIANJIN MEDICAL 2012-06-20 CN claimed
US-7572757-B1 Method of treating a well with a gel stabilizer BJ SERVICES COMPANY (US) 2009-08-11 US claimed
US-20050124684-A1 5-(hydroxymethyl) furfural and derivatives as inhibitors of TNFalpha and IL-1beta production HUTCHISON MEDIPHARMA ENTERPRISES LIMITED (BS) 2005-06-09 US claimed
US-20040185347-A1 Non-aqueous electrolyte and a lithium secondary battery comprising the same SAMSUNG SDI CO., LTD. (KR) 2004-09-23 US claimed
EP-1458048-A1 A non-aqueous electrolyte and a lithium secondary battery comprising the same Samsung SDI Co., Ltd. (KR) 2004-09-15 EP claimed
EP-0674233-B1 Recording sheets XEROX CORP (US) 2000-05-24 EP claimed
US-5928765-A Recording sheets XEROX CORPORATION (US) 1999-07-27 US claimed
EP-0674233-A2 Recording sheets XEROX CORPORATION (US) 1995-09-27 EP claimed